Corticosteroid therapy for conservative management in marginally-viable pregnancy complicated by HELLP syndrome

By Dreyfus M.   Tissier I.   Ndocko M.-A.   Denoual I.   Baldauf J.-J.   Ritter J.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 85, Iss. 2, 1999-08 ,pp. : 233-234

Elsevier

Access to resources Recommend Favorite

Is conservative treatment for adenocarcinoma in situ of the cervix safe?

By Soutter W.P.   Haidopoulos D.   Gornall R.J.   McIndoe G.A.   Fox J.   Mason W.P.   Flanagan A.   Nicholas N.   Barker F.   Abrahams J.   Lampert I.   Sarhanis P.  

British Journal of Obstetrics and Gynaecology, Vol. 108, Iss. 11, 2001-11 ,pp. : 1184-1189

Elsevier

Access to resources Recommend Favorite

The effects of betamethasone treatment on clinical and laboratory features of pregnant women with HELLP syndrome

By Ozer Alev  

Archives of Gynecology and Obstetrics, Vol. 280, Iss. 1, 2009-07 ,pp. : 65-70

Springer Publishing Company

Access to resources Recommend Favorite

Surgical treatment of HELLP syndrome-associated liver rupture - an update

By Reck T.   Bussenius-Kammerer M.   Ott R.   Muller V.   Beinder E.   Hohenberger W.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 99, Iss. 1, 2001-11 ,pp. : 57-65

Elsevier

Access to resources Recommend Favorite

Plasmapheresis in the management of HELLP syndrome

By Eckford S. D.   Macnab J. L.   Turner M. L.   Plews D.   Liston W. A.  

Journal of Obstetrics & Gynaecology, Vol. 18, Iss. 4, 1998-07 ,pp. : 377-379

Informa Healthcare

Access to resources Recommend Favorite